STAT+: Pharmalittle: We’re reading about FDA seeking more data on a Lilly obesity pill, a pharma 340B win, and more

The FDA asked Eli Lilly for more data on liver injury linked to its newly approved obesity pill, Foundayo
Source
Stat News
Opens original article in a new tab



